Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT00701220
Eligibility Criteria:
Inclusion Criteria:
* Ischemic Cardiomyopathy (as defined above) with ejection fraction \< 35%
* Non-ischemic Cardiomyopathy with ejection fraction \< 35%
* NCEP ATPIII indication for therapy with a statin drug
* No statin therapy within previous 6 months of study enrollment
* Prescribed stable doses of standard heart failure therapies including beta blocking agents, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and diuretic agents as required
Exclusion Criteria:
* Pregnant or lactating
* Myocardial infarction within 6 months preceding study enrollment
* Primary valvular heart disease
* Surgical or catheter based revascularization within the preceding 6 months
* Documented viral or inflammatory myocarditis or cardiomyopathy
* Peripartum cardiomyopathy
* Infiltrative cardiomyopathies
* Chemotherapy associated cardiomyopathy
* Without indication for statin therapy
* Contraindication to statin therapy including hepatic dysfunction, history of rhabdomyolysis or prior intolerance of statin therapy
* Contraindication to magnetic resonance imaging
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00701220
Study Brief:
Protocol Section:
NCT00701220